US EditionPublished • loading... • Updated
Rovi Signs with Roche the Manufacture in Spain of a Medicine for Obesity and Diabetes
Summary by The Objective | Periodismo Ethos
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Rovi has signed an agreement with the Swiss company Roche to manufacture a new medicine for obesity and diabetes that will boost between 20% and 25% sales of its manufacturing business to third parties in 2030, according to the Spanish pharmaceutical company reported this Tuesday to the National Securities Market Commission (CNMV). Specifically, Rovi, through its subsidiary Rois, has formally closed the final agreement of collaboration with Roch…
·Madrid, Spain
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
